Document is current
Any future updates will be listed below
-
Authors
Deodhar, Atul https://orcid.org/0000-0002-2130-1246
Kim, Tae-Jong https://orcid.org/0000-0002-2871-1635
Navarro-Compán, Victoria https://orcid.org/0000-0002-4527-852X
Fonseca, Sergio https://orcid.org/0009-0008-3687-5964
Antunes, José https://orcid.org/0000-0003-3505-6314
Singh, Arun
Milek, Richard https://orcid.org/0009-0003-4055-2686
Wu, Jordan https://orcid.org/0009-0000-2192-338X
Ramiro, Sofia https://orcid.org/0000-0002-8899-9087
- License Information
-
More Information
Article History
Received: 27 May 2026
Accepted: 21 July 2026
First Online: 10 August 2026
Declarations
Conflict of Interest: Atul Deodhar is a consultant and serves on advisory boards for Bristol Myers Squibb, Lilly, Johnson & Johnson, Novartis, Pfizer, and UCB. Dr. Deodhar has received research grants from Bristol Myers Squibb, Lilly, Johnson & Johnson, MoonLake, Novartis, Pfizer, and UCB. Tae-Jong Kim received consulting and speaking fees from Johnson & Johnson, Lilly, Novartis, Pfizer, AbbVie, and UCB. Dr. Kim received research grants from Samsung Bioepis, Celltrion, LG Chem, Novartis, and Pfizer. Victoria Navarro-Compán has received research grants/honoraria from AbbVie, Alfasigma, Janssen, Lilly, Novartis, Pfizer, and UCB. Sergio Fonseca, José Antunes, Arun Singh, and Jordan Wu are employees of Johnson & Johnson and shareholders of Johnson & Johnson stock. Richard Milek was employed by Johnson & Johnson through the initial submission and revision of this manuscript and remains a shareholder. Sofia Ramiro received research grants or consultancy fees from AbbVie, Alfasigma, Lilly, Johnson & Johnson, MSD, Novartis, Pfizer, Takeda, and UCB.
Ethical Approval: This narrative review is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
